KIT pathway upregulation predicts dasatinib efficacy in acute myeloid leukemia.

Malani D, Yadav B, Kumar A, Potdar S, Kontro M, Kankainen M, Javarappa KK, Porkka K, Wolf M, Aittokallio T, Wennerberg K, Heckman CA, Murumägi A, Kallioniemi O

Leukemia 34 (10) 2780-2784 [2020-10-00; online 2020-07-17]

PubMed 32678289

DOI 10.1038/s41375-020-0978-7

Crossref 10.1038/s41375-020-0978-7

pii: 10.1038/s41375-020-0978-7


Publications 9.5.1